marketcaparena

NUS

NU SKIN ENTERPRISES, INC.

Company overview

Market capitalization
$225.86M
Employees
2,800
Latest publication
2026-09-29
About NU SKIN ENTERPRISES, INC.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USD
Total Revenue320,112,000USD320,608,000USD370,320,000USD364,211,000USD386,138,000USD430,145,000USD417,306,000USD488,640,000USD
Cost Of Revenue101,787,000USD106,145,000USD108,339,000USD107,488,000USD120,405,000USD128,682,000USD123,242,000USD136,215,000USD
Gross Profit218,325,000USD214,463,000USD261,981,000USD256,723,000USD265,733,000USD301,463,000USD294,064,000USD352,425,000USD
Selling General Administrative90,847,000USD98,544,000USD107,395,000USD104,817,000USD106,725,000USD115,620,000USD124,566,000USD145,033,000USD
General And Administrative Expenses90,847,000USD———————
Total Operating Expenses277,644,000USD208,598,000USD238,737,000USD235,081,000USD234,953,000USD283,232,000USD285,242,000USD336,362,000USD
Operating Income-59,319,000USD5,865,000USD23,244,000USD21,642,000USD30,780,000USD18,231,000USD8,822,000USD16,063,000USD
Total Other Income Expense Net-3,856,000USD-3,266,000USD-5,053,000USD-5,648,000USD-3,369,000USD-4,933,000USD-7,721,000USD-6,735,000USD
Interest Expense3,322,000USD4,250,000USD3,994,000USD4,145,000USD2,526,000USD6,500,000USD7,325,000USD1,476,000USD
Income Before Tax-63,175,000USD2,599,000USD18,191,000USD15,994,000USD27,411,000USD13,298,000USD1,101,000USD9,328,000USD
Income Tax Expense186,623,000USD763,000USD3,700,000USD-1,085,000USD6,292,000USD4,996,000USD1,634,000USD2,046,000USD
Net Income-249,798,000USD1,836,000USD14,491,000USD17,079,000USD21,119,000USD8,302,000USD-533,000USD7,282,000USD
Selling And Marketing Expenses—110,054,000USD—130,264,000USD128,228,000USD167,612,000USD153,542,000USD—
Net Interest Income—-4,250,000USD-3,994,000USD-4,145,000USD-2,526,000USD-6,500,000USD-7,325,000USD—
Tax Provision—763,000USD3,700,000USD-1,085,000USD6,292,000USD4,996,000USD1,634,000USD2,046,000USD
Net Income From Continuing Ops—1,836,000USD14,491,000USD17,079,000USD21,119,000USD8,302,000USD-533,000USD7,282,000USD
Ebit—6,849,000USD22,185,000USD20,139,000USD29,937,000USD19,798,000USD8,426,000USD9,328,000USD
Ebitda—19,191,000USD35,097,000USD32,230,000USD42,989,000USD37,119,000USD26,863,000USD26,589,000USD
Depreciation And Amortization—12,342,000USD12,912,000USD12,091,000USD13,052,000USD17,321,000USD18,437,000USD17,261,000USD
Reconciled Depreciation—12,342,000USD12,912,000USD12,091,000USD13,052,000USD17,321,000USD18,437,000USD18,584,000USD
Research Development——10,800,000USD————22,600,000USD
Unclassified Operating Expenses——120,542,000USD———7,134,000USD168,729,000USD
Interest Income——3,994,000USD4,145,000USD2,526,000USD6,500,000USD——
Net Income Applicable To Common Shares——14,491,000USD17,079,000USD21,119,000USD8,302,000USD——
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
Total Revenue1,485,159,000USD1,969,131,000USD2,225,659,000USD2,695,669,000USD2,581,934,000USD2,420,416,000USD2,679,008,000USD2,279,099,000USD
Cost Of Revenue453,761,000USD611,850,000USD630,915,000USD675,223,000USD658,028,000USD581,420,000USD634,140,000USD502,078,000USD
Gross Profit1,031,398,000USD1,357,281,000USD1,594,744,000USD2,020,446,000USD1,923,906,000USD1,838,996,000USD2,044,868,000USD1,777,021,000USD
Selling General Administrative432,141,000USD546,858,000USD555,769,000USD666,395,000USD646,848,000USD615,970,000USD662,302,000USD564,514,000USD
Selling And Marketing Expenses508,380,000USD742,365,000USD879,634,000USD1,068,189,000USD————
Total Operating Expenses940,521,000USD1,309,013,000USD1,483,897,000USD1,786,454,000USD1,666,342,000USD1,571,570,000USD1,733,322,000USD1,502,538,000USD
Operating Income90,877,000USD48,268,000USD110,847,000USD233,992,000USD257,564,000USD267,426,000USD240,860,000USD274,483,000USD
Interest Income42,048,000USD25,600,000USD13,500,000USD11,000,000USD13,100,000USD19,200,000USD21,800,000USD7,900,000USD
Interest Expense13,948,000USD25,560,000USD21,877,000USD11,000,000USD13,100,000USD19,200,000USD0USD0USD
Net Interest Income-13,948,000USD-25,560,000USD-13,493,000USD—————
Income Before Tax196,197,000USD26,578,000USD88,970,000USD232,459,000USD256,232,000USD255,172,000USD219,666,000USD265,567,000USD
Income Tax Expense35,993,000USD17,983,000USD-15,808,000USD85,193,000USD64,877,000USD81,619,000USD97,779,000USD136,130,000USD
Tax Provision35,993,000USD-16,923,000USD-15,808,000USD85,193,000USD64,877,000USD81,619,000USD97,779,000USD136,130,000USD
Net Income160,204,000USD8,595,000USD104,778,000USD147,266,000USD191,355,000USD173,553,000USD121,887,000USD129,437,000USD
Net Income From Continuing Ops160,204,000USD58,528,000USD104,778,000USD147,266,000USD191,355,000USD173,553,000USD121,887,000USD129,437,000USD
Ebit210,145,000USD133,758,000USD102,463,000USD243,459,000USD257,564,000USD267,426,000USD219,666,000USD274,483,000USD
Ebitda262,406,000USD202,981,000USD174,969,000USD368,483,000USD331,555,000USD344,076,000USD302,669,000USD346,047,000USD
Depreciation And Amortization52,261,000USD69,223,000USD72,506,000USD125,024,000USD73,991,000USD76,650,000USD83,003,000USD71,564,000USD
Reconciled Depreciation52,261,000USD70,910,000USD72,506,000USD76,320,000USD73,991,000USD76,650,000USD83,003,000USD71,564,000USD
Total Other Income Expense Net105,320,000USD-21,690,000USD-21,877,000USD-1,533,000USD-1,332,000USD-12,254,000USD-21,194,000USD-8,916,000USD
Net Income Applicable To Common Shares160,204,000USD8,595,000USD104,778,000USD147,266,000USD191,355,000USD173,553,000USD121,887,000USD129,437,000USD
Research Development—22,600,000USD23,300,000USD27,200,000USD23,300,000USD30,100,000USD23,000,000USD22,000,000USD
Unclassified Operating Expenses——25,194,000USD24,670,000USD996,194,000USD925,500,000USD1,048,020,000USD916,024,000USD
Non Operating Income Net Other——-21,877,000USD-1,533,000USD-1,332,000USD-12,254,000USD-21,194,000USD-8,916,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets1,121,530,000USD1,376,798,000USD1,405,313,000USD1,424,406,000USD1,443,693,000USD1,391,411,000USD1,468,914,000USD1,582,895,000USD
Cash And Equivalents189,643,000USD—238,630,000USD251,787,000USD264,159,000USD203,770,000USD186,883,000USD227,751,000USD
Cash And Short Term Investments191,386,000USD200,405,000USD239,841,000USD252,997,000USD264,159,000USD213,551,000USD197,994,000USD237,828,000USD
Short Term Investments1,743,000USD1,751,000USD1,211,000USD1,210,000USD1,211,000USD9,781,000USD11,111,000USD10,077,000USD
Total Current Assets508,149,000USD522,888,000USD547,698,000USD548,143,000USD571,553,000USD524,857,000USD538,599,000USD653,371,000USD
Other Current Assets76,364,000USD98,870,000USD84,714,000USD67,721,000USD67,314,000USD65,954,000USD99,579,000USD98,942,000USD
Other Non Current Assets125,755,000USD———————
Total Liabilities578,791,000USD———————
Total Current Liabilities256,347,000USD256,997,000USD263,733,999USD254,437,000USD283,906,000USD260,300,000USD296,607,000USD339,351,000USD
Other Current Liabilities198,636,000USD———————
Other Non Current Liabilities78,705,000USD———————
Total Stockholder Equity542,739,000USD794,087,000USD805,240,000USD799,795,000USD787,754,000USD753,969,000USD651,455,000USD706,875,000USD
Total Equity Including Noncontrolling Interest542,739,000USD———————
Short Long Term Debt20,000,000USD20,000,000USD20,000,000USD20,000,000USD35,000,000USD20,000,000USD30,000,000USD60,000,000USD
Long Term Debt193,664,000USD203,593,000USD204,187,000USD209,044,000USD213,900,000USD218,757,000USD363,613,000USD373,470,000USD
Deferred Revenue6,300,000USD———————
Net Receivables48,902,000USD45,013,000USD39,544,000USD48,892,000USD59,703,000USD56,576,000USD50,784,000USD68,812,000USD
Inventory191,497,000USD178,600,000USD183,599,000USD178,533,000USD180,377,000USD188,776,000USD190,242,000USD247,789,000USD
Property Plant Equipment Net444,992,000USD451,960,000USD458,875,000USD455,213,000USD451,943,000USD459,456,000USD466,908,000USD496,223,000USD
Goodwill4,750,000USD———————
Intangible Assets37,884,000USD39,290,000USD42,614,000USD44,198,000USD45,937,000USD47,554,000USD74,278,000USD85,266,000USD
Accounts Payable37,711,000USD28,815,000USD26,183,000USD28,523,000USD28,734,000USD33,590,000USD34,880,000USD32,736,000USD
Common Stock91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD
Retained Earnings1,606,571,000USD1,859,282,000USD1,860,319,000USD1,848,734,000USD1,834,617,000USD1,816,462,000USD1,711,949,000USD1,751,037,000USD
Accumulated Other Comprehensive Income-118,152,000USD-236,754,000USD-116,105,000USD-116,916,000USD-114,058,000USD-123,850,000USD-124,758,000USD-105,040,000USD
Total Liab—582,711,000USD600,073,000USD624,611,000USD655,939,000USD637,442,000USD817,459,000USD876,020,000USD
Other Current Liab—201,982,000USD199,110,999USD198,614,000USD212,772,000USD206,710,000USD175,977,000USD246,615,000USD
Capital Stock—91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD
Good Will—83,625,000USD83,625,000USD83,625,000USD83,625,000USD83,625,000USD83,625,000USD99,885,000USD
Cash—198,654,000USD238,630,000USD251,787,000USD264,159,000USD203,770,000USD186,883,000USD227,751,000USD
Current Deferred Revenue—6,200,000USD—7,300,000USD7,400,000USD—15,688,000USD—
Net Debt—78,956,000USD125,623,000USD39,639,000USD46,578,000USD96,936,000USD291,342,000USD274,070,000USD
Short Term Debt—20,000,000USD38,440,000USD20,000,000USD35,000,000USD20,000,000USD47,922,000USD60,000,000USD
Short Long Term Debt Total—277,610,000USD364,253,000USD291,426,000USD310,737,000USD300,706,000USD478,225,000USD501,821,000USD
Property Plant Equipment Gross—451,960,000USD862,086,000USD455,213,000USD451,943,000USD459,456,000USD819,863,000USD496,223,000USD
Common Stock Shares Outstanding—49,422,000shares49,912,000shares50,310,000shares49,499,000shares50,328,000shares49,712,000shares49,733,000shares
Non Current Assets Total—853,910,000USD857,615,000USD876,262,999USD872,140,000USD866,554,000USD930,315,000USD929,524,000USD
Non Current Liabilities Total—325,714,000USD336,339,000USD370,174,000USD372,033,000USD377,142,000USD520,852,000USD536,669,000USD
Non Current Liabilities Other—68,104,000USD7,132,000USD98,748,000USD96,296,000USD96,436,000USD7,478,000USD94,848,000USD
Non Currrent Assets Other—279,035,000USD253,756,000USD293,226,999USD290,635,000USD275,919,000USD91,665,000USD248,150,000USD
Net Working Capital—265,891,000USD283,964,000USD293,706,000USD287,647,000USD264,557,000USD241,992,000USD314,020,000USD
Unclassified Current Liabilities—-20,000,000USD-20,000,000USD-20,000,000USD-35,000,000USD-20,000,000USD-7,860,000USD-60,000,000USD
Unclassified Non Current Liabilities—54,017,000USD125,020,000USD62,382,000USD61,837,000USD61,949,000USD149,761,000USD68,351,000USD
Unclassified Equity—-828,623,000USD-939,156,000USD-932,205,000USD-932,987,000USD-938,825,000USD-935,918,000USD-939,304,000USD
Other Assets——280,187,000USD293,227,000USD290,635,000USD275,919,000USD320,212,000USD248,150,000USD
Long Term Investments——18,745,000USD———39,590,000USD—
Unclassified Non Current Assets——-280,187,000USD-293,227,000USD-290,635,000USD-275,919,000USD-145,963,000USD-248,150,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets1,405,313,000USD1,468,914,000USD1,806,463,000USD1,820,970,000USD1,906,480,000USD1,957,076,000USD1,769,006,000USD1,694,446,000USD
Intangible Assets42,614,000USD74,278,000USD105,309,000USD66,701,000USD76,991,000USD89,532,000USD80,321,000USD89,989,000USD
Other Current Assets89,670,000USD99,579,000USD81,198,000USD87,816,000USD76,906,000USD101,563,000USD69,854,000USD51,877,000USD
Total Liab600,073,000USD817,459,000USD984,495,000USD923,674,000USD993,708,000USD1,062,805,000USD893,717,000USD912,579,000USD
Total Stockholder Equity805,240,000USD651,455,000USD821,968,000USD897,296,000USD912,772,000USD894,271,000USD875,289,000USD781,867,000USD
Other Current Liab199,111,000USD175,977,000USD195,227,000USD202,029,000USD274,500,000USD307,708,000USD201,113,000USD257,112,000USD
Common Stock91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD
Capital Stock91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD91,000USD
Retained Earnings1,860,319,000USD1,711,949,000USD1,870,470,000USD1,939,497,000USD1,911,734,000USD1,840,740,000USD1,727,772,000USD1,635,751,000USD
Good Will83,625,000USD83,625,000USD230,768,000USD206,432,000USD206,432,000USD202,979,000USD196,573,000USD196,573,000USD
Other Assets253,756,000USD271,081,000USD197,899,000USD244,429,000USD175,460,000USD293,186,000USD154,016,000USD144,112,000USD
Cash238,630,000USD186,883,000USD256,057,000USD264,725,000USD339,593,000USD402,683,000USD335,630,000USD386,911,000USD
Cash And Equivalents238,630,000USD186,883,000USD256,057,000USD264,725,000USD339,593,000USD402,683,000USD335,630,000USD386,911,000USD
Cash And Short Term Investments239,841,000USD197,994,000USD267,816,000USD278,509,000USD354,814,000USD423,899,000USD344,043,000USD398,257,000USD
Total Current Assets547,698,000USD538,599,000USD701,871,000USD759,868,000USD872,950,000USD903,198,000USD740,166,000USD799,237,000USD
Total Current Liabilities263,734,000USD296,607,000USD328,871,000USD359,243,000USD529,694,000USD542,856,000USD356,760,000USD439,655,000USD
Net Debt125,623,000USD291,342,000USD351,273,000USD255,797,000USD164,192,000USD97,694,000USD171,381,000USD43,552,000USD
Short Term Debt38,440,000USD47,922,000USD48,898,000USD54,376,000USD140,927,000USD74,981,000USD66,849,000USD69,455,000USD
Short Long Term Debt20,000,000USD30,000,000USD25,000,000USD25,000,000USD107,500,000USD30,000,000USD27,500,000USD69,455,000USD
Short Long Term Debt Total364,253,000USD478,225,000USD607,330,000USD520,522,000USD503,785,000USD500,377,000USD507,011,000USD430,463,000USD
Long Term Debt204,187,000USD363,613,000USD478,040,000USD377,466,000USD268,781,000USD305,393,000USD334,461,000USD361,008,000USD
Long Term Investments18,745,000USD39,590,000USD36,374,000USD39,493,000USD35,868,000USD11,344,000USD——
Short Term Investments1,211,000USD11,111,000USD11,759,000USD13,784,000USD15,221,000USD21,216,000USD8,413,000USD11,346,000USD
Net Receivables39,544,000USD50,784,000USD72,879,000USD47,360,000USD41,299,000USD63,370,000USD50,378,000USD53,282,000USD
Inventory178,643,000USD190,242,000USD279,978,000USD346,183,000USD399,931,000USD314,366,000USD275,891,000USD295,821,000USD
Accounts Payable26,183,000USD34,880,000USD43,113,000USD53,963,000USD49,993,000USD66,174,000USD38,979,000USD47,617,000USD
Property Plant Equipment Net451,189,000USD466,908,000USD523,072,000USD571,671,000USD598,245,000USD653,453,000USD644,824,000USD464,535,000USD
Property Plant Equipment Gross862,086,000USD819,863,000USD897,613,000USD444,806,000USD453,674,000USD653,453,000USD597,930,000USD464,535,000USD
Accumulated Other Comprehensive Income-116,105,000USD-124,758,000USD-100,006,000USD-86,509,000USD-73,896,000USD-64,768,000USD-85,292,000USD-79,934,000USD
Common Stock Shares Outstanding50,301,000shares49,662,000shares49,860,000shares50,525,000shares51,427,000shares52,765,000shares55,927,000shares56,476,000shares
Non Current Assets Total857,615,000USD930,315,000USD1,104,592,000USD1,061,102,000USD1,033,530,000USD1,053,878,000USD1,028,840,000USD895,209,000USD
Non Current Liabilities Total336,339,000USD520,852,000USD655,624,000USD564,431,000USD464,014,000USD519,949,000USD536,957,000USD472,924,000USD
Non Current Liabilities Other7,132,000USD7,478,000USD8,950,000USD76,540,000USD88,759,000USD112,275,000USD105,701,000USD27,768,000USD
Non Currrent Assets Other261,442,000USD91,665,000USD99,806,000USD87,035,000USD89,511,000USD61,156,000USD76,342,000USD144,112,000USD
Net Working Capital283,964,000USD241,992,000USD373,000,000USD400,625,000USD343,256,000USD360,342,000USD383,406,000USD359,582,000USD
Unclassified Non Current Assets-253,756,000USD-96,832,000USD-88,636,000USD-154,659,000USD-148,977,000USD-257,772,000USD-123,236,000USD-144,112,000USD
Unclassified Current Liabilities-20,000,000USD-7,860,000USD-3,755,000USD—-76,365,000USD28,939,000USD—-24,088,000USD
Unclassified Non Current Liabilities125,020,000USD149,761,000USD168,634,000USD12,140,000USD———-27,768,000USD
Unclassified Equity-939,156,000USD-935,918,000USD-948,678,000USD-955,874,000USD601,612,000USD579,710,000USD557,453,000USD552,473,000USD
Current Deferred Revenue—15,688,000USD20,388,000USD27,053,000USD33,139,000USD35,054,000USD20,162,000USD20,104,000USD
Other Liab———98,285,000USD106,474,000USD102,281,000USD96,795,000USD111,916,000USD
Net Tangible Assets———897,296,000USD912,772,000USD894,271,000USD875,289,000USD781,867,000USD
Treasury Stock————-1,526,860,000USD-1,461,593,000USD-1,324,826,000USD-1,326,605,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation25,000,000USD
Stock Based Compensation4,812,000USD
Change To Account Receivables-10,007,000USD
Change To Inventory-21,260,000USD
Change To Liabilities-17,606,000USD
Change In Working Capital-10,161,000USD
Operating Cash Flow6,706,000USD
Capital Expenditures-19,352,000USD
Net Investments-573,000USD
Investing Cash Flow-19,925,000USD
Net Debt Issuance-10,978,000USD
Net Common Stock Issuance-5,011,000USD
Common Dividends Paid-5,786,000USD
Other Financing Activities-6,500,000USD
Unclassified Financing Cash Flow-5,505,000USD
Financing Cash Flow-33,780,000USD
Effect Of Forex Changes On Cash-1,988,000USD
Change In Cash-48,987,000USD
End Cash Flow189,643,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income1,836,000USD14,491,000USD17,079,000USD21,119,000USD107,515,000USD-36,105,000USD8,302,000USD-118,258,000USD
Depreciation12,342,000USD12,912,000USD12,091,000USD13,052,000USD14,206,000USD16,449,000USD17,321,000USD17,603,000USD
Stock Based Compensation3,695,000USD3,160,000USD5,819,000USD5,818,000USD9,308,000USD3,445,000USD3,490,000USD3,646,000USD
Other Non Cash Items11,956,000USD14,493,999USD8,742,000USD10,712,000USD-112,459,000USD79,516,000USD-28,389,000USD155,874,000USD
Change To Account Receivables-5,737,000USD8,737,000USD9,978,000USD-2,782,000USD-5,878,000USD-12,837,000USD3,680,000USD-6,053,000USD
Change To Inventory-5,882,000USD884,000USD94,000USD10,941,000USD-32,000USD5,370,000USD2,012,000USD15,937,000USD
Change In Working Capital-35,471,000USD-28,436,000USD-14,889,000USD-7,482,000USD-18,812,000USD10,332,000USD36,019,000USD-3,996,000USD
Total Cash From Operating Activities-3,919,000USD16,620,999USD27,481,000USD35,795,000USD389,000USD25,785,000USD31,432,000USD51,207,000USD
Capital Expenditures-13,714,000USD-10,760,000USD-9,915,000USD-18,000USD-13,584,000USD-12,583,000USD-8,596,000USD-8,123,000USD
Free Cash Flow-17,633,000USD5,860,999USD17,566,000USD35,777,000USD-13,195,000USD13,202,000USD22,836,000USD43,084,000USD
Investments-573,000USD0USD-9,915,000USD8,793,000USD181,544,000USD-13,622,000USD-6,547,000USD-8,531,000USD
Total Cashflows From Investing Activities-14,287,000USD-9,760,000USD-9,915,000USD8,793,000USD181,544,000USD-13,622,000USD-6,547,000USD-8,531,000USD
Net Borrowings-489,000USD-5,483,000USD-20,635,000USD9,501,000USD-155,621,000USD-40,584,000USD-25,742,000USD—
Total Cash From Financing Activities-20,399,000USD-18,501,000USD-26,876,000USD9,268,000USD-166,295,000USD-43,626,000USD-28,778,000USD-28,817,000USD
Dividends Paid-2,873,000USD-2,906,000USD-2,962,000USD-2,964,000USD-3,002,000USD-2,983,000USD-2,983,000USD-2,982,000USD
Sale Purchase Of Stock-5,011,000USD-10,020,000USD-5,037,000USD20,000USD-5,012,000USD2,004,000USD-53,000USD-60,000USD
Change In Cash-39,976,000USD-13,157,000USD-12,372,000USD60,389,000USD16,887,000USD-40,868,000USD3,501,000USD11,718,000USD
Begin Period Cash Flow238,630,000USD251,787,000USD264,159,000USD203,770,000USD186,883,000USD227,751,000USD224,250,000USD212,532,000USD
End Period Cash Flow198,654,000USD238,630,000USD251,787,000USD264,159,000USD203,770,000USD186,883,000USD227,751,000USD224,250,000USD
Other Cashflows From Financing Activities-10,657,000USD-418,000USD1,758,000USD2,711,000USD-2,660,000USD-2,886,000USD-53,000USD-60,000USD
Unclassified Operating Cash Flow1,723,000USD—-1,361,000USD-7,424,000USD—-47,852,000USD-5,311,000USD-3,662,000USD
Unclassified Financing Cash Flow-1,369,000USD——————-25,715,000USD
Other Cashflows From Investing Activities—1,000,000USD193,725,000USD203,939,000USD193,725,000USD3,621,000USD1USD-408,000USD
Unclassified Investing Cash Flow——-183,810,000USD-203,921,000USD-180,141,000USD8,962,000USD8,595,999USD8,531,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income160,204,000USD-146,594,000USD8,595,000USD104,778,000USD147,266,000USD191,355,000USD173,553,000USD121,887,000USD
Depreciation52,261,000USD69,810,000USD70,923,000USD72,506,000USD76,320,000USD73,991,000USD76,650,000USD83,003,000USD
Stock Based Compensation24,105,000USD14,823,000USD15,646,000USD12,367,000USD23,194,000USD24,060,000USD9,909,000USD26,609,000USD
Other Non Cash Items-86,685,000USD257,515,000USD123,248,000USD62,712,000USD82,601,000USD49,085,000USD48,289,000USD58,052,000USD
Change To Account Receivables10,055,000USD-7,763,000USD-22,679,000USD-11,449,000USD20,219,000USD-11,207,000USD2,746,000USD-10,453,000USD
Change To Inventory11,887,000USD30,318,000USD-13,222,000USD40,314,000USD-95,320,000USD-31,137,000USD18,446,000USD-33,371,000USD
Change In Working Capital-69,619,000USD-28,335,000USD-81,683,000USD-92,675,000USD-193,620,000USD52,564,000USD-132,435,000USD-71,884,000USD
Total Cash From Operating Activities80,286,000USD111,742,000USD118,639,000USD108,062,000USD141,582,000USD379,141,000USD177,931,000USD202,738,000USD
Capital Expenditures-34,277,000USD-41,583,000USD-58,490,000USD-59,056,000USD-68,615,000USD-63,823,000USD-66,067,000USD-70,371,000USD
Free Cash Flow46,009,000USD70,159,000USD60,149,000USD49,006,000USD72,967,000USD315,318,000USD111,864,000USD132,367,000USD
Investments10,214,000USD-37,962,000USD-132,488,000USD-8,023,000USD-1,148,000USD-656,000USD2,728,000USD116,000USD
Total Cashflows From Investing Activities170,662,000USD-37,962,000USD-134,501,000USD-67,079,000USD-88,726,000USD-79,428,000USD-71,412,000USD-108,761,000USD
Net Borrowings-172,238,000USD-112,886,000USD96,802,000USD22,423,000USD40,000,000USD-27,500,000USD-69,455,000USD22,655,000USD
Total Cash From Financing Activities-202,404,000USD-133,176,000USD10,730,000USD-99,504,000USD-104,702,000USD-245,166,000USD-154,794,000USD-116,714,000USD
Dividends Paid-11,834,000USD-11,927,000USD-77,622,000USD-77,015,000USD-76,272,000USD-78,387,000USD-82,189,000USD-80,581,000USD
Sale Purchase Of Stock-20,040,000USD-2,063,000USD-13,011,000USD-70,045,000USD-80,420,000USD-144,334,000USD-825,000USD-69,565,000USD
Change In Cash51,747,000USD-69,174,000USD-8,668,000USD-74,868,000USD-63,090,000USD67,053,000USD-51,281,000USD-39,488,000USD
Begin Period Cash Flow186,883,000USD256,057,000USD264,725,000USD339,593,000USD402,683,000USD335,630,000USD386,911,000USD426,399,000USD
End Period Cash Flow238,630,000USD186,883,000USD256,057,000USD264,725,000USD339,593,000USD402,683,000USD335,630,000USD386,911,000USD
Other Cashflows From Investing Activities194,725,000USD3,621,000USD-76,011,000USD-8,023,000USD-18,963,000USD-14,949,000USD-8,073,000USD116,000USD
Other Cashflows From Financing Activities1,382,000USD-6,300,000USD-3,198,000USD481,975,000USD168,861,000USD120,764,000USD142,675,000USD3,534,000USD
Unclassified Operating Cash Flow—-55,477,000USD-18,090,000USD-51,626,000USD5,821,000USD-11,914,000USD1,965,000USD-14,929,000USD
Unclassified Investing Cash Flow—37,962,000USD132,488,000USD8,023,000USD———-38,622,000USD
Unclassified Financing Cash Flow——7,759,000USD-456,842,000USD-156,871,000USD-115,709,000USD-145,000,000USD7,243,000USD
Change To Liabilities———-127,397,000USD-113,859,000USD126,677,000USD-69,083,000USD-27,411,000USD
Cash And Cash Equivalents Changes———-58,521,000USD-63,090,000USD67,053,000USD-51,281,000USD-39,488,000USD
Exchange Rate Changes————-11,244,000USD12,506,000USD-3,006,000USD-16,751,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
FY 2025Yearly · 2025-12-31ProductBeauty568,113,000USD0001140361-26-005130
FY 2025Yearly · 2025-12-31ProductOther Product Lines227,984,000USD0001140361-26-005130
FY 2025Yearly · 2025-12-31ProductWellness689,062,000USD0001140361-26-005130
FY 2024Yearly · 2024-12-31ProductBeauty681,765,000USD0001140361-26-005130
FY 2024Yearly · 2024-12-31ProductOther Product Lines293,102,000USD0001140361-26-005130
FY 2024Yearly · 2024-12-31ProductWellness757,217,000USD0001140361-26-005130
FY 2023Yearly · 2023-12-31ProductBeauty858,625,000USD0001140361-26-005130
FY 2023Yearly · 2023-12-31ProductOther Product Lines224,413,000USD0001140361-26-005130
FY 2023Yearly · 2023-12-31ProductWellness886,093,000USD0001140361-26-005130
FY 2022Yearly · 2022-12-31ProductBeauty1,069,714,000USD0001140361-25-004907
FY 2022Yearly · 2022-12-31ProductOther Product Lines163,607,000USD0001140361-25-004907
FY 2022Yearly · 2022-12-31ProductWellness992,338,000USD0001140361-25-004907
FY 2021Yearly · 2021-12-31ProductBeauty1,442,659,000USD0001140361-24-008111
FY 2021Yearly · 2021-12-31ProductOther Product Lines190,461,000USD0001140361-24-008111
FY 2021Yearly · 2021-12-31ProductWellness1,062,549,000USD0001140361-24-008111
FY 2020Yearly · 2020-12-31ProductBeauty1,491,803,000USD0001140361-23-007348
FY 2020Yearly · 2020-12-31ProductOther Product Lines167,578,000USD0001140361-23-007348
FY 2020Yearly · 2020-12-31ProductWellness922,553,000USD0001140361-23-007348
FY 2019Yearly · 2019-12-31ProductOther Product Lines133,806,000USD0001140361-21-004212
FY 2019Yearly · 2019-12-31ProductPersonal Care1,423,485,000USD0001140361-21-004212
FY 2019Yearly · 2019-12-31ProductWellness863,125,000USD0001140361-21-004212
Q2 2019Quarterly · 2019-06-30GeographyAmericas Pacific92,841,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographyChina185,333,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographyEMEA43,400,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographyHong Kong Taiwan43,712,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographyJapan65,251,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographyOther1,249,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographySouth Korea84,732,000USD0001140361-19-014385
Q2 2019Quarterly · 2019-06-30GeographySoutheast Asia75,395,000USD0001140361-19-014385
Q1 2019Quarterly · 2019-03-31GeographyAmericas Pacific86,456,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographyChina208,488,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographyEMEA41,818,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographyHong Kong Taiwan40,558,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographyJapan62,109,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographySouth Korea83,853,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31GeographySoutheast Asia72,495,000USD0001140361-19-008097
Q1 2019Quarterly · 2019-03-31SegmentCorporate-1,426,000USD0001140361-20-010880
Q1 2019Quarterly · 2019-03-31SegmentGrow Tech0USD0001140361-20-010880
Q1 2019Quarterly · 2019-03-31SegmentManufacturing35,172,000USD0001140361-20-010880
Q1 2019Quarterly · 2019-03-31SegmentNu Skin594,351,000USD0001140361-20-010880
FY 2018Yearly · 2018-12-31ProductOther Product Lines97,943,000USD0001140361-21-004212
FY 2018Yearly · 2018-12-31ProductPersonal Care1,659,737,000USD0001140361-21-004212
FY 2018Yearly · 2018-12-31ProductWellness921,328,000USD0001140361-21-004212
Q4 2018Quarterly · 2018-12-31ProductNu Skin422,190,000USDLegacy provider
Q4 2018Quarterly · 2018-12-31ProductOther Product Lines27,558,000USDLegacy provider
Q4 2018Quarterly · 2018-12-31ProductPharmanex233,539,000USDLegacy provider
Q3 2018Quarterly · 2018-09-30GeographyAmericas Pacific93,580,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographyChina226,645,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographyEMEA42,819,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographyHong Kong Taiwan44,949,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographyJapan63,649,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographyOther1,378,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographySouth Korea89,963,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30GeographySoutheast Asia86,307,000USD0001140361-19-019870
Q3 2018Quarterly · 2018-09-30ProductNu Skin384,635,000USD0001140361-18-042662
Q3 2018Quarterly · 2018-09-30ProductOther Product Lines28,785,000USD0001140361-18-042662
Q3 2018Quarterly · 2018-09-30ProductPharmanex261,892,000USD0001140361-18-042662
Q2 2018Quarterly · 2018-06-30GeographyAmericas Pacific103,990,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographyChina245,256,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographyEMEA44,010,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographyHong Kong Taiwan52,206,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographyJapan64,113,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographyOther1,030,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographySouth Korea91,624,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30GeographySoutheast Asia79,223,000USD0001140361-19-014385
Q2 2018Quarterly · 2018-06-30ProductNu Skin466,462,000USD0001021561-18-000115
Q2 2018Quarterly · 2018-06-30ProductOther Product Lines24,730,000USD0001021561-18-000115
Q2 2018Quarterly · 2018-06-30ProductPharmanex212,998,000USD0001021561-18-000115
Q1 2018Quarterly · 2018-03-31GeographyAmericas Pacific92,289,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographyChina197,531,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographyEMEA44,981,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographyHong Kong Taiwan40,992,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographyJapan63,224,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographySouth Korea88,930,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31GeographySoutheast Asia70,860,000USD0001140361-19-008097
Q1 2018Quarterly · 2018-03-31ProductNu Skin386,450,000USD0001021561-18-000066
Q1 2018Quarterly · 2018-03-31ProductOther Product Lines16,870,000USD0001021561-18-000066
Q1 2018Quarterly · 2018-03-31ProductPharmanex212,899,000USD0001021561-18-000066
Q4 2017Quarterly · 2017-12-31ProductNu Skin470,921,000USDLegacy provider
Q4 2017Quarterly · 2017-12-31ProductOther Product Lines1,096,000USDLegacy provider
Q4 2017Quarterly · 2017-12-31ProductPharmanex194,184,000USDLegacy provider
Q3 2017Quarterly · 2017-09-30GeographyAmericas Pacific85,672,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographyChina172,556,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographyEMEA40,133,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographyHong Kong Taiwan41,050,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographyJapan62,513,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographyOther1,395,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographySouth Korea89,238,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30GeographySoutheast Asia71,141,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30ProductNu Skin338,305,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30ProductOther Product Lines1,362,000USD0001140361-18-042662
Q3 2017Quarterly · 2017-09-30ProductPharmanex224,031,000USD0001140361-18-042662
Q2 2017Quarterly · 2017-06-30GeographyAmericas Pacific82,997,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographyChina172,098,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographyEMEA38,188,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographyHong Kong Taiwan43,071,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographyJapan64,796,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographyOther1,489,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographySouth Korea86,917,000USD0001021561-18-000115
Q2 2017Quarterly · 2017-06-30GeographySoutheast Asia60,545,000USD0001021561-18-000115

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.